⚕ GalenOps CRO console
← 710 (USA)

710-1264

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2013-06-13
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-09-29 (study day 109.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 119.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 121.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-09-29 (study day 109.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 119.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 121.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-07-03 (study day 21.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-21 (study day 70.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-21 (study day 70.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.